###### Strengths and limitations of this study

-   This rapid review of guidance focused on management in paediatric wards affected by COVID-19 will help paediatric healthcare providers take action in their wards.

-   We employed the Appraisal of Guidelines for Research and Evaluation II tool, a scientifically valid instrument used to assess article quality, to summarise all key recommendations, after which we compared the inconsistencies among them.

-   We included documents published in Chinese or English only, thereby running the risk of neglecting essential documents from regions in which Chinese or English is not the first language.

-   Unconscious bias from a subjective rating of documents was inevitable. Therefore, we avoided inviting coauthors of the guidance documents to be reviewers in order to prevent subconscious competing interests, and we conducted two rounds of group discussions to minimise subjective bias.

Introduction {#s1}
============

On 30 January 2020, the WHO announced that the COVID-19 epidemic was a public health emergency of international concern.[@R1] The COVID-19 pandemic is developing rapidly. According to the latest WHO data, as of 10:00 China Standard Time on 26 July 2020, there were 15 785 641 confirmed cases of COVID-19 and 640 016 deaths worldwide, involving 215 countries or regions.[@R2]

In China, the Law on the Prevention and Treatment of Infectious Diseases divides such diseases into three categories in descending order of severity. COVID-19 has been categorised into category B (which covers nearly 30 diseases, including SARS and COVID-19), although prevention and control have been carried out in accordance with category A (which covers only bubonic plague and cholera) guidelines. National-level policy specifications such as diagnosis, treatment plans and protection guidelines have been issued, which provide a basis for the standardised clinical diagnosis and control of COVID-19. In the current reported cases of the COVID-19 pandemic, patients of all ages have been infected. Studies have already reported COVID-19 infection in children.[@R3] Therefore, paediatric professional groups and paediatric experts in all municipalities have formulated guidelines and consensuses on the topic of paediatric COVID-19, also involving the diagnosis and treatment of diseases in general, and the prevention and control of nosocomial infections.

During the process of COVID-19 prevention and control, standardisation of the management for the entire paediatric ward is important. This requires the implementation of reasonable standardised and humane management strategies designed to provide managers with the ability to take appropriate actions in order to deal with major emergencies, and to offer acceptable methods to care for children with suspected and confirmed cases, as well as their families, especially vulnerable neonates. These are the challenges and existing problems for clinical staffs facing the outbreak.

Therefore, this study was conducted to summarise and analyse the published articles concerning the management in paediatric wards affected by COVID-19, compare any differences and provide recommendations to paediatric medical staffs and hospital managers for the adjustment of existing hospital prevention and control strategies.

Method {#s2}
======

Literature search and search strategies {#s2-1}
---------------------------------------

A systematic search (last updated before 31 May 2020) was conducted to retrieve relevant guidelines and consensuses concerning the management in paediatric wards facing COVID-19. The major academic databases included PubMed, EMBASE, the Cochrane Library, UpToDate, China National Knowledge Infrastructure, the Wanfang database and relevant websites such as medline.cn, dxy.cn, the National Health and Health Commission and the China Center for Disease Control and Prevention, each of which was searched systematically. Search terms included novel coronavirus, coronavirus pneumonia, COVID, COVID-19, NCP, nCoV, guideline, consensus, recommendation, opinion, pediatrics, children, newborn, and others. The search strategies are listed in [online supplementary appendix 1](#SP1){ref-type="supplementary-material"}.

10.1136/bmjopen-2020-039897.supp1

Inclusion and exclusion criteria {#s2-2}
--------------------------------

The inclusion criteria included: (1) the target group of the article was patients with COVID-19; (2) guidelines, consensuses, recommendations or expert opinions issued by international or national/regional organisations or associations; (3) inpatient wards, isolation ward management, childcare and personnel management; (4) latest version; (5) published in Chinese or English; and (6) full text available. The exclusion criteria included: (1) interpretation version; (2) translated version; (3) literature type was a research plan or proposal. Two reviewers (WZ and QL) independently screened all searched articles. Disagreements between the reviewers were resolved via face-to-face discussion with a third reviewer (PN).

Data extraction {#s2-3}
---------------

All of the included studies were imported into the EndNote software platform. Two reviewers (WL and JS) independently extracted and cross-checked relevant data (article characteristics, recommendations for management) from each included article. Data extraction was conducted in Microsoft Excel. In order to ensure data validity and accuracy, the data collection was completed by two researchers independently. Disagreements were resolved by discussion.

Quality assessment {#s2-4}
------------------

The 23-item Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool[@R4] across six domains (scope and purpose, stakeholder involvement, rigour of development, clarity of presentation, applicability and editorial independence) was used by two researchers (WZ and QL) to independently evaluate the quality of each article. Each item was assigned a score ranging from 1 (strongly disagree) to 7 (strongly agree) points. The score for each domain was calculated by summing all scores of the individual items in a domain and then standardised as a percentage using the following equation: domain score=(obtained score−minimal possible score)/(maximal possible score−minimal possible score).[@R5] The overall assessment included whether the articles could be recommended for clinical practice.[@R5] An overall assessment of each article is included in the AGREE II tool: if the score is \>60%, the grade is 'strongly recommended for use in practice'; if the score is between 30% and 60%, the grade is 'recommended for use with some modification'; if the score is \<30%, the grade is 'not recommended for use in practice'.[@R6]

Patient and public involvement {#s2-5}
------------------------------

Patients were not involved in this research.

Data analysis {#s2-6}
-------------

The means and SDs for the AGREE II domains were calculated and presented. The intraclass correlation coefficients (ICCs) were used for testing inter-rater reliability among researchers.[@R7] ICC values from 0.81 to 1.00 were considered to be the most consistent.[@R8] SPSS V.22.0 software was used for statistical analysis.

Results {#s3}
=======

Search results {#s3-1}
--------------

Our systematic search yielded a total of 792 records after duplicates were removed, and 738 were excluded due to irrelevant issues after screening by title and abstract. After assessment of the full text, 19 of the remainder were excluded, leaving a total of 35 articles[@R9] that met the selection criteria. The screening process and results are illustrated in [figure 1](#F1){ref-type="fig"}.

![Flow chart of the literature research. Adapted from Moher *et al*.[@R55]](bmjopen-2020-039897f01){#F1}

Characteristics of included articles {#s3-2}
------------------------------------

The 35 selected studies were conducted by various medical organisations and published in the year 2020. These articles were composed of 3 sets of consensus guidelines, 25 expert consensuses and 7 expert opinions. Thirteen were written in English, 23 in Chinese. Of the total 35 papers, 24 were from China, 2 from the USA, 1 from Spain, 1 from Brazil, 1 from Saudi Arabia and 6 from multinational cooperative efforts. Five were second editions, while the rest were first editions. The number of participating centres ranged from 1 to 57. The results are listed in [online supplementary appendix 2](#SP2){ref-type="supplementary-material"}.
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Quality scores {#s3-3}
--------------

The ICC for AGREE II was 0.898 (95% CI 0.884 to 0.911), indicating that the consistency was excellent. See [online supplementary appendix 2](#SP2){ref-type="supplementary-material"} for the results.

Content summary and analysis {#s3-4}
----------------------------

### Nosocomial infection and control {#s3-4-1}

There were 13 recommendations for nosocomial infection and control, concerning ward setting and personal protection management. In the personal protection management, there are three levels of protection. Level I protection: uniform, medical/surgical mask, hand hygiene, disposable latex gloves, disposable hats and isolation clothing (level I+). Level II protection: work clothes, a medical protective mask (N95), hand hygiene, disposable latex gloves, a disposable hat, goggles or a protective mask (level II+), isolation clothing, medical protective clothing (level II+) and shoe covers. Level III protection: work clothes, a medical protective mask (N95), hand hygiene, disposable latex gloves, a disposable hat, goggles or a protective mask, isolation clothing, medical protective clothing, shoe covers and (when necessary) comprehensive respiratory protectors. All the recommendations came from 25 articles of varying quality. A summary of these recommendations is provided in [online supplementary appendix 3](#SP3){ref-type="supplementary-material"}.
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#### Isolation ward setting {#s3-4-1-1}

1.  In the isolation ward setting, a child suspected of having COVID-19 needs a single-occupant room.[@R10]

2.  Diagnosed children can stay in the same room.[@R10]

3.  Critically ill children should be sent to a negative pressure room in the intensive care unit (ICU).[@R11]

4.  If a newborn or premature infant's mother is suspected of having or suffering from COVID-19, the infant should be transferred to an isolation room.[@R15]

5.  Incubators are recommended as isolation tools for newborns.[@R14]

#### Isolation ward: personal protection management {#s3-4-1-2}

1.  For personal protection management in the isolation ward, at least level II protection[@R10] or perhaps level III protection[@R9] is required.

#### General ward setting {#s3-4-1-3}

1.  In the general ward setting, a transitional ward could be set up for patients.[@R15]

2.  A single-occupant room is needed for children in the haematology and oncology departments.[@R17]

#### General ward: personal protection management {#s3-4-1-4}

1.  For personal protection management in the general ward, level I protection is basically required.[@R17]

2.  Level II protection is required in special departments, such as the infectious disease department[@R10] and the in-centre haemodialysis department.[@R34]

#### Special procedures: personal protection management {#s3-4-1-5}

1.  For personal protection management during special procedures that could produce aerosols, no less than level II protection[@R10] or perhaps level III protection[@R15] is required.

2.  For the disposal of disposable medical waste, chlorine-containing solution should be used to spray the outside of waste bags,[@R14] and disinfection should be performed for \>10 min[@R14] before transport.

3.  Non-disposable medical fabrics should be sprayed with chlorine-containing disinfectant solution for \>10 min before transport.[@R14]

### Human resource management {#s3-4-2}

There were four recommendations for human resource management in wards, which were derived from 11 articles of varying quality. A summary of the recommendations is tabulated in [online supplementary appendix 4](#SP4){ref-type="supplementary-material"}.
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1.  Medical staff should be provided to isolation wards according to national standards[@R14] or to the severity of patients' conditions[@R31] to ensure adequate human resources.[@R34]

2.  Rotation of medical staff in isolation wards every half month[@R26] or 1 month[@R20] is needed to ensure adequate rest for staff.[@R34]

3.  All medical staff should be trained in the latest knowledge of COVID-19,[@R34] disease-related nosocomial infection prevention and control,[@R14] and psychological crisis intervention.[@R20] In addition, simulation training specific to managing suspected COVID-19 cases should be in place in every suite.[@R38]

4.  Psychological counselling should be provided for staff in fever clinics and isolation observation wards by counsellors, social workers, volunteers or professional societies.[@R17]

### Management of paediatric patients and their families {#s3-4-3}

There were 12 recommendations for the management of paediatric patients and their families in hospital wards, which were derived from 26 articles of varying quality. A summary of the recommendations is tabulated in [online supplementary appendix 5](#SP5){ref-type="supplementary-material"}.

10.1136/bmjopen-2020-039897.supp5

#### Chaperones {#s3-4-3-1}

1.  In the general ward, chaperones should be limited to one person for each paediatric patient,[@R17] and they should be required to wear masks and have their temperatures monitored.[@R17]

2.  It is inconclusive as to whether chaperones should be permitted in the isolation ward[@R21] if specifically needed, and whether there should be only one chaperone who is taking protective measures.[@R19]

3.  In the neonatal ward, chaperones are not allowed to leave the neonatal ward.[@R28]

#### Visitors {#s3-4-3-2}

1.  Visitors are not allowed in the neonatal ward,[@R14] isolation ward,[@R16] haematology and oncology ward[@R17] or transitional ward[@R21] unless specifically needed.[@R26]

2.  If the patient is in critical condition, the visitor must enter via the designated route and take strict protective measures before entering.[@R26]

3.  For non-COVID-19 mother--infant dyads, mothers of neonates in the neonatal ICU (NICU) are encouraged to visit their babies.[@R42]

4.  Daily screening for respiratory symptoms and influenza syndrome is recommended for fathers and mothers visiting newborns.[@R35]

5.  Video visits are recommended.[@R38]

6.  Day care visits in the otolaryngology ward should be reduced.[@R37]

#### Breast feeding {#s3-4-3-3}

1.  For non-COVID-19 mother--infant dyads, in which mother and infant are not separated, mothers are encouraged to breast feed directly. Otherwise, mothers should express breast milk regularly.[@R31]

2.  For suspected or confirmed COVID-19 mother--infant dyads in the isolation room, where mother and infant are separated, direct breast feeding is avoided.[@R14] Mothers can express breast milk and offer it to their newborns via caregivers.[@R18] In areas with a high risk of outbreaks, it is better to use breast milk after it has tested negative for COVID-19[@R23] or been pasteurised in advance.[@R12] Breast feeding should cease if mothers are extremely sick,[@R42] nor should it be performed during antiviral treatment.[@R12]

#### Psychological counselling {#s3-4-3-4}

1.  Psychological counselling is needed for paediatric patients and their families[@R11] through doctors, social workers or support consultants via telemedicine.[@R16]

Discussion {#s4}
==========

Only 3 sets of guideline, 25 expert consensuses and 7 expert opinions concerning management in paediatric wards facing COVID-19 have been published in a mere 5 months. Based on the varying quality of the reviewed guidance documents, there are still opportunities for further enhancements of methodological rigour. The majority of the documents provided clear descriptions in the domains of 'scope and purpose' and 'clarity of presentation'. In addition, only a small proportion of the documents demonstrated potential conflicts of interest. Detailed explanations of any conflicts of interest are needed, so as to facilitate readers' judgements.[@R44] The lowest AGREE II domain score was for 'rigor of development', which judged the strict process of guideline development or the evidence assessment method.[@R45] In response to the sudden outbreak of COVID-19, China's provinces and cities immediately launched level I prevention and control measures in order to control the spread of the epidemic during its early stage. Since patients with suspected cases of coronavirus infection will be sent to designated medical institutions across the country, it is important and urgent for experts from hospitals to quickly generate relevant prevention and control guidance for limiting the spread of COVID-19. Given this urgency, the expert group in this study had limited time to use traditional methodological techniques. Although some methodological rigour and evidence application evaluation were not satisfactory, the proposed guidance seemed to be effective in terms of the experience of antiepidemic treatment in epidemic areas. Moreover, some of the guidance proposals were updated during the study period, and provided valuable recommendations for all paediatric medical staff and managers.

According to a previous study[@R46] of nosocomial outbreaks of SARS in hospitals, administrative factors such as cleaning, protection, protective equipment, workload of healthcare staff and training are important in both causing and preventing nosocomial outbreaks. Currently, COVID-19 could spread via various medical activities,[@R47] and most paediatric patients are vulnerable, especially those in the neonatal, haematology and oncology wards. It is therefore vital for the healthcare providers to focus more on the topic of management in paediatric inpatient wards in this situation. In our review, paediatric inpatient wards should operate according to the relevant local policy on the prevention and treatment of infectious diseases. For the nosocomial infection and control in our review, it was clear that the recommendations in different categories were consistent, including the set-up of isolation areas, the division of general wards and the protection requirements, as well as the disposal of medical waste. There were, however, some recommendation conflicts among the proposals for personal protection management in the isolation area and the implementation of special procedures (including aerosol-generating procedures and the collection of respiratory samples). No less than level II protection is required in isolation wards.[@R10] For the same situation, however, some of the articles suggest upgrading the protection level to level III.[@R9] In addition, when clinical staff conduct aerosol-generating procedures, some of the articles propose the highest level of protection,[@R15] while others suggest maintaining the original level.[@R10] This may depend on the storage of an adequate amount of personal protective equipment and the function of a ward to cure the patients with confirmed cases of COVID-19. Although there was one low-quality consensus, the recommendations were consistent with the high-quality and medium-quality documents.

The recommendations in our review were consistent in terms of the human resource management of the ward. The ward managers need to assign medical staff to isolation wards according to national standards[@R14] or to the severity of patients' conditions[@R31] to ensure adequate human resources.[@R34] Thus, to ensure adequate rest[@R34] for staff, rotation every half month[@R26] or 1 month[@R20] is recommended. In addition, it was suggested that the managers relay the latest knowledge of COVID-19[@R34] and disease-related nosocomial infection prevention and control training[@R14] to all medical staff. As simulation is an optimal tool for improving multidisciplinary collaboration, communication and testing of system-based resources in order to maximise safety of response to real-time events,[@R48] simulation training specific to managing suspected COVID-19 cases[@R38] is recommended. At the same time, employees may experience certain pressure and anxiety due to occupational exposure, work overload, cumbersome prevention and control procedures, and other factors.[@R28] Therefore, psychological counselling was recommended by high-quality^[@R43]^ and medium-quality[@R17] articles for all medical staff during their employment.

In addition to the management of medical staff, the management of paediatric patients and their families is also vital in this situation. First, whether or not isolation areas should allow parents to accompany their children was not determined in this study. Four documents[@R21] recommended against allowing one parent chaperone, with protective measures taken, if specifically needed.[@R19] Second, in the general wards, each patient could be accompanied by one parent.[@R17] Additional requirements for the parents included the wearing of medical masks and daily temperature monitoring.[@R17] It was recommended that visitors not be permitted in the isolation area[@R16] or in certain wards hosting vulnerable patients such as the neonatal ward,[@R14] haematology and oncology ward[@R17] or transitional ward[@R21] unless specifically needed.[@R26] If the patient is in critical condition, the visitor must enter via the designated route and take strict protective measures before entering.[@R26] Techniques such as video visits are recommended[@R38] for maintaining the safety of isolated areas while simultaneously relieving the separation anxiety of paediatric patients. In addition, visitation of neonates by their mothers was encouraged for non-COVID-19 mother--infant dyads and for neonates in the NICU,[@R42] and daily screening for respiratory symptoms and influenza syndrome is recommended for fathers and mothers visiting newborns.[@R35] Third, five documents in this review agreed on the breast feeding management of hospitalised children. For non-COVID-19 mother--infant dyads, in which mother and infant are not separated, mothers are encouraged to breast feed directly; otherwise, they should express breast milk regularly.[@R31] It is not clear whether the novel coronavirus can be transmitted through breast milk, and evidence is currently insufficient on the safety of breast feeding and the need for mother--baby separation. WHO guidelines recommend using freshly expressed breast milk without pasteurisation,[@R49] and other scientific institutions and societies support this evidence.[@R50] Considering that certain viruses (like cytomegalovirus and herpes simplex virus) can be transmitted by this route,[@R54] we recommend a cautious approach in our review. For suspected or confirmed COVID-19 mother--infant dyads in the isolation room, where mother and infant are separated, direct breast feeding should be avoided.[@R14] Mothers can express breast milk and offer it to their newborns via caregivers.[@R35] In areas with high risk of outbreaks, it is better to use breast milk after it has tested negative for COVID-19[@R23] or been pasteurised in advance.[@R12] Furthermore, breast feeding should cease if mothers are extremely sick,[@R42] nor should it be performed during antiviral treatment.[@R12]

Finally, more attention should be paid to hospitalised children and their families,[@R11] and it is also essential to provide psychological counselling via telemedicine during the epidemic.[@R16] All of the recommendations were consistent among low, medium and high-quality documents.

Strengths and limitations {#s4-1}
-------------------------

Our review has several strengths. First is the rapid review of guidance focused on management in paediatric wards being impacted by COVID-19. Hence, the results of this review will help paediatric healthcare providers take action in their wards. Second, we used the AGREE II tool, which is a scientific and valid instrument used to assess article quality, and summarised all key recommendations, after which we compared the inconsistencies among them. This review also had some limitations. We only included documents published in Chinese or English, thereby running the risk of neglecting essential documents from regions in which Chinese or English is not the first language. Moreover, unconscious bias from a subjective rating of documents was inevitable. We avoided inviting coauthors of the guidance documents as reviewers in order to prevent subconscious competing interests and conducted two rounds of group discussions to minimise subjective bias.

Conclusions {#s5}
===========

Due to the sudden and rapid spread of COVID-19, the quality of quick guidance and consensuses for management in paediatric wards is not high. In the future, it will be necessary to systematically formulate high-quality guidelines and consensuses for paediatric ward management based on COVID-19. Complete hospital preparedness is critical for the early detection and management of public health emergencies. This will help to enhance a hospital's capacity for emergency response, improve the quality of medical care and minimise the directionless output of manpower and equipment, and even loss of life.
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